Cargando…
Biased efficacy estimates in phase-III dengue vaccine trials due to heterogeneous exposure and differential detectability of primary infections across trial arms
Vaccine efficacy (VE) estimates are crucial for assessing the suitability of dengue vaccine candidates for public health implementation, but efficacy trials are subject to a known bias to estimate VE toward the null if heterogeneous exposure is not accounted for in the analysis of trial data. In lig...
Autores principales: | España, Guido, Hogea, Cosmina, Guignard, Adrienne, ten Bosch, Quirine A., Morrison, Amy C., Smith, David L., Scott, Thomas W., Schmidt, Alexander, Perkins, T. Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347271/ https://www.ncbi.nlm.nih.gov/pubmed/30682037 http://dx.doi.org/10.1371/journal.pone.0210041 |
Ejemplares similares
-
A dynamic transmission model with age-dependent infectiousness and reactivation for cytomegalovirus in the United States: Potential impact of vaccination strategies on congenital infection
por: Hogea, Cosmina, et al.
Publicado: (2015) -
Local and regional dynamics of chikungunya virus transmission in Colombia: the role of mismatched spatial heterogeneity
por: Moore, Sean M., et al.
Publicado: (2018) -
An agent-based model of dengue virus transmission shows how uncertainty about breakthrough infections influences vaccination impact projections
por: Perkins, T. Alex, et al.
Publicado: (2019) -
How radical is radical cure? Site-specific biases in clinical trials underestimate the effect of radical cure on Plasmodium vivax hypnozoites
por: Huber, John H., et al.
Publicado: (2021) -
Pokémon Go and Exposure to Mosquito-Borne Diseases: How Not to Catch ‘Em All
por: Oidtman, Rachel J., et al.
Publicado: (2016)